Company Information
Industry 信息传输、软件和信息技术服务业
Company Introduction 广西慧球科技股份有限公司原是一家通过国家科技部和中国科学院"双高"认定、广西区重点支持的高新技术生物制药企业,主要生产临床上广泛使用的基因工程产品、人体组织工程材料、血液制品、生物生化药品、化学药、中成药等,公司自主研制开发的J-I型脱细胞异体真皮被列入国家"火炬计划",并获得美国专利.公司拥有各类先进的生产设备其中关键生产检测设备,如发酵系统、超滤系统等均从国外引进,精良的设备为生产高质量的产品提供了坚实的物质保障.公司旗下企业均已通过国家GMP认证,GMP车间建筑面积达4万多平米.2009年,因陷入严重的财务危机,公司下属企业相继停产,生产经营所需流动资金严重不足,已无法清偿到期债务,致使债权人起诉本公司。公司2009年1至10月执行重组,在此期间公司各项生产经营活动均已停止,将主要经营性资产通过拍卖等形式已用于清偿债务。破产重整计划执行完毕后,2012年12月公司通过无偿受赠形式获得杭州物业100%股权,公司主营业务变更为物业管理服务,恢复了盈利能力。
Main Business 通信技术、信息科技、计算机、电子科技的技术开发、技术服务、技术咨询, 计算机网络工程, 计算机软硬件开发, 通讯器材、自动化控制系统的销售、设计、安装及售后服务,从事货物及技术的进出口业务。
Legal Representative 李檬
Top Executives
董事长:李檬
董事:葛景栋,曹菲,梁京辉
独立董事:高勇,高奕峰,徐斓
Top 5 Shareholder
Shareholder name Nature Holding Date
ShowWorld HongKong Limited流通A股18.40%30/06/2024
WB Online Investment Limited流通A股8.17%30/06/2024
北海利兹利投资合伙企业(有限合伙)流通A股7.04%30/06/2024
北海永盟投资合伙企业(有限合伙)流通A股5.28%30/06/2024
海南庥隆金实私募基金管理中心(有限合伙)流通A股2.56%30/06/2024
Company Secretary 于悦
Solicitors 北京市通商律师事务所
Auditors 中汇会计师事务所(特殊普通合伙)
Tel No 010-64666131
Fax No 010-65815719
Website www.inmyshow.com
Email ir@inmyshow.com
Company Address
Register: 广西北海市四川路356号北海软件园3幢
Office: 北京市朝阳区三里屯西五街5号院D座
Listing Date 07/08/2001
Shares Capital
Shares Capital: 1,807,747,642
Total A Share: 1,807,747,642
Listed A Share: 1,807,747,642
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.050
DPS(RMB)* ¥ 0.016
NBV Per Share(RMB)* ¥ 2.121
Market Capitalization(RMB) 6.327B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.